Improvements in Relapsed or Refractory Follicular Lymphoma: How Experts Individualize Treatment Strategies

This comprehensive program on relapsed/refractory follicular lymphoma will help align your clinical practice with expert recommendations and new findings through an Interactive Decision Support Tool with treatment recommendations from 5 experts, an expert-authored online activity, and a downloadable slideset to use in your own presentations or for self-study.
John M. Burke, MD
Ian W. Flinn, MD, PhD
Christopher R. Flowers, MD, MS
Jonathan W. Friedberg, MD
John P. Leonard, MD
Jeff P. Sharman, MD


This CME-certified interactive module provides expert insight on the evolving treatment landscape for relapsed/refractory follicular lymphoma, including treatment options for patients experiencing early progression or transformation, the role of transplantation, and emerging therapies.

Jonathan W. Friedberg, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: September 27, 2019 Expired: September 26, 2020

Downloadable Slideset

Download these slides to review the latest clinical data informing optimal management of patients with relapsed/refractory follicular lymphoma.

Jonathan W. Friedberg, MD Released: September 27, 2019

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with relapsed/refractory follicular lymphoma with those of 5 renowned lymphoma experts.

John M. Burke, MD Ian W. Flinn, MD, PhD Christopher R. Flowers, MD, MS John P. Leonard, MD Jeff P. Sharman, MD Released: March 25, 2020
Provided by Purdue University and Clinical Care Options, LLC
Purdue University Logo

Accreditation: Dawn Sinclair, Purdue University
Certificates/Credits: Heather Holley, Purdue University

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?